The GSR is an expansion of the highly successful Fred Hutchinson Cancer Research Center (FHCRC) DNA (deoxyribonucleic acid) Array Laboratory launched in 1998, which was one of the first microarray core laboratories in the country. Initially, the resource was instrumental in assisting researchers in the development of a number of novel microarray applications, including assays examining protein-DNA interactions, DNA methylation profiling, and DNA replication timing patterns. The resource then transitioned from primarily making custom spotted arrays to using several commercial array-based platforms. The DNA Array Lab was later incorporated into a new entity - the Consortium Genomics Shared Resource - along with a newly developed second laboratory, the Genetic Analysis Lab, which was developed to provide capillary-based sequencing services (and years later also provide NextGen sequencing services). This expansion also required an expansion of support infrastructure and instrumentation for the main service areas. A major component of this infrastructure is HutchBASE, an in-house developed Laboratory Information and Management System (LIMS) system that supports online ordering of services, sample tracking, data management and analysis, and billing. The resource provides the highest quality services and expertise to aid the genomics-based needs of Cancer Consortium members through its two laboratories. The Genetic Analysis Laboratory provides: ? Capillary-based and NextGen sequencing technologies; ? Genotyping; and ? Quantitative (real-time) polymerase chain reaction (qPCR) services. The deoxyribonucleic acid (DNA) Array Laboratory provides Consortium members with end-to-end solutions for array-based experimentation, including: ? Consultation on technology selection; ? Assistance with experimental design; ? Assessment of RNA and DNA quality; ? Troubleshooting support; and ? Assistance with reviewing data quality and implementation of data analysis strategies.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA015704-44
Application #
9617707
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2019-01-01
Budget End
2019-12-31
Support Year
44
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
078200995
City
Seattle
State
WA
Country
United States
Zip Code
98109
Cheng, Heather H (2018) The resounding effect of DNA repair deficiency in prostate cancer. Urol Oncol 36:385-388
Poudel, Kumud R; Roh-Johnson, Minna; Su, Allen et al. (2018) Competition between TIAM1 and Membranes Balances Endophilin A3 Activity in Cancer Metastasis. Dev Cell 45:738-752.e6
Holly, Mayumi K; Smith, Jason G (2018) Adenovirus infection of human enteroids reveals interferon sensitivity and preferential infection of goblet cells. J Virol :
Eaton, Keith D; Romine, Perrin E; Goodman, Gary E et al. (2018) Inflammatory Gene Polymorphisms in Lung Cancer Susceptibility. J Thorac Oncol 13:649-659
Bar, Merav; Flowers, Mary E D; Storer, Barry E et al. (2018) Reversal of Low Donor Chimerism after Hematopoietic Cell Transplantation Using Pentostatin and Donor Lymphocyte Infusion: A Prospective Phase II Multicenter Trial. Biol Blood Marrow Transplant 24:308-313
Gauthier, Jordan; Turtle, Cameron J (2018) Insights into cytokine release syndrome and neurotoxicity after CD19-specific CAR-T cell therapy. Curr Res Transl Med 66:50-52
Graves, Scott S; Parker, Maura H; Stone, Diane et al. (2018) Anti-Inducible Costimulator Monoclonal Antibody Treatment of Canine Chronic Graft-versus-Host Disease. Biol Blood Marrow Transplant 24:50-54
Amundsen, Susan K; Smith, Gerald R (2018) The RecB helicase-nuclease tether mediates Chi hotspot control of RecBCD enzyme. Nucleic Acids Res :
Méndez, Eduardo; Rodriguez, Cristina P; Kao, Michael C et al. (2018) A Phase I Clinical Trial of AZD1775 in Combination with Neoadjuvant Weekly Docetaxel and Cisplatin before Definitive Therapy in Head and Neck Squamous Cell Carcinoma. Clin Cancer Res 24:2740-2748
Buckley, Sarah A; Percival, Mary-Elizabeth; Othus, Megan et al. (2018) A comparison of patients with acute myeloid leukemia and high-risk myelodysplastic syndrome treated on versus off study. Leuk Lymphoma :1-7

Showing the most recent 10 out of 1267 publications